These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9001402)

  • 1. Isolation and characterization of the bioactive circulating human parathyroid hormone, hPTH-1-37.
    Hock D; Mägerlein M; Heine G; Ochlich PP; Forssmann WG
    FEBS Lett; 1997 Jan; 400(2):221-5. PubMed ID: 9001402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
    Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.
    Jin L; Briggs SL; Chandrasekhar S; Chirgadze NY; Clawson DK; Schevitz RW; Smiley DL; Tashjian AH; Zhang F
    J Biol Chem; 2000 Sep; 275(35):27238-44. PubMed ID: 10837469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34.
    Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR
    J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of a novel recombinant peptide derived from hPTH(1-34).
    Chunxiao W; Jingjing L; Yire X; Jingning L; Kai K; Liang S; Yi L; Rasco B
    Protein Expr Purif; 2011 Sep; 79(1):156-63. PubMed ID: 21569852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
    D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
    J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
    Kawata T; Imanishi Y; Kobayashi K; Onoda N; Takemoto Y; Tahara H; Okuno S; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5774-8. PubMed ID: 16046589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.
    D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T
    Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
    Hackeng WH; Lips P; Netelenbos JC; Lips CJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
    D'Amour P; Brossard JH; Rousseau L; Nguyen-Yamamoto L; Nassif E; Lazure C; Gauthier D; Lavigne JR; Zahradnik RJ
    Kidney Int; 2005 Sep; 68(3):998-1007. PubMed ID: 16105030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
    Brossard JH; Yamamoto LN; D'Amour P
    Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal fragments of human parathyroid hormone in parathyroid tumors: unique new source of immunogens for the production of antisera potentially useful in the radioimmunoassay of parathyroid hormone in human serum.
    Di Bella FP; Gilkinson JB; Flueck J; Arnaud CD
    J Clin Endocrinol Metab; 1978 Apr; 46(4):604-12. PubMed ID: 755044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 69-84 amino acid region of the parathyroid hormone molecule is essential for the interaction of the hormone with the binding sites with carboxyl-terminal specificity.
    Takasu H; Baba H; Inomata N; Uchiyama Y; Kubota N; Kumaki K; Matsumoto A; Nakajima K; Kimura T; Sakakibara S; Fujita T; Chihara K; Nagai I
    Endocrinology; 1996 Dec; 137(12):5537-43. PubMed ID: 8940381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera.
    Fischer JA; Binswanger U; Dietrich FM
    J Clin Invest; 1974 Dec; 54(6):1382-94. PubMed ID: 4474187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human parathyroid hormone synthesized in Escherichia coli. Purification and characterization.
    Rabbani SA; Yasuda T; Bennett HP; Sung WL; Zahab DM; Tam CS; Goltzman D; Hendy GN
    J Biol Chem; 1988 Jan; 263(3):1307-13. PubMed ID: 3275665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of human parathyroid hormone (28-48): attempt to develop an assay for intact human parathyroid hormone.
    Mallette LE
    Metab Bone Dis Relat Res; 1983; 4(6):329-32. PubMed ID: 6664305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of creatine kinase activity in rat skeletal tissue in vivo and in vitro by protease-resistant variants of parathyroid hormone fragments.
    Sömjen D; Vargas V; Waisman A; Wingender E; Tegge W; Kaye AM
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):85-90. PubMed ID: 7619087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ concentration influences the hepatic extraction of bioactive human PTH-(1-34) in rats.
    D'Amour P; Huet PM
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E87-92. PubMed ID: 2912143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and cyclic AMP stimulation by N-terminally deleted human PTHs (3-84 and 4-84) in a homologous ligand receptor system.
    Olstad OK; Reppe S; Loseth OP; Jemtland R; Gautvik KM
    J Bone Miner Res; 1997 Sep; 12(9):1348-57. PubMed ID: 9286750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P; D'Amour P
    Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.